Maria G. Cavallo
Rome, 00161, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Soluble CD14 Levels Predict Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Independently of Obesity and Type 2 Diabetes.
Journal: International journal of molecular sciences
Published: February 25, 2026
Neuroprotective strategies for cognitive decline in type 2 diabetes.
Journal: Trends in endocrinology and metabolism: TEM
Published: February 09, 2026
Fibrotic NASH Index (FNI) Is Associated with Long-Term Mortality in Individuals with Type 2 Diabetes and MASLD.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 18, 2025
Adipose Tissue Dysfunction and Metabolic Diseases: The Role of Vitamin D/Vitamin D Receptor Axis.
Journal: International journal of molecular sciences
Published: September 15, 2025
Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 24, 2025
Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD).
Journal: International journal of molecular sciences
Published: December 23, 2024
Correction: Modelling the long-term health impact of COVID-19 using Graphical Chain Models.
Journal: BMC infectious diseases
Published: September 11, 2024
Waist circumference, among metabolic syndrome components, predicts degraded trabecular bone score: a retrospective study of a female population from the 2005-2008 NHANES cohorts.
Journal: Frontiers in endocrinology
Published: August 06, 2024
Circulating Proneurotensin Levels Predict Impaired Bone Mineralisation in Postmenopausal Women With Type 2 Diabetes Mellitus.
Journal: Diabetes/metabolism research and reviews
Published: August 06, 2024
Neurotensin: Linking metabolism and cardiovascular disease.
Journal: Atherosclerosis
Published: February 27, 2024
Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study.
Journal: Diabetes, obesity & metabolism
Published: December 22, 2023
Last Updated: 09/26/2026